The research marks a pivotal step in understanding protein dynamics and offering clarity to biopharmaceutical ... could ...

The Global Biologics CDMO Market is expected to witness a growth rate of 14-16% in the next five years. Growing ...

These insights help researchers fine-tune biopharmaceutical processes, reducing development timelines and increasing the likelihood of regulatory approval. Regulatory compliance is another area where ...

The biopharmaceutical landscape stands at ... and expedite the overall gene therapy development timeline. Accelerating pre-clinical gene target discovery The overwhelming volume of large-scale ...

US biotech company SparX Biopharmaceutical has signed a research agreement with Mitsubishi Tanabe Pharma America aimed at ...

GC Biopharma has partnered with Körber to implement a large-scale Manufacturing Execution System (MES) project across ...

Accelerated Delivery Timelines - Over One Month ... from cell line construction and process development to cGMP manufacturing of biopharmaceutical products. The company's extensive expertise ...

ProBioGen inks agreement with Polpharma Biologics to provide high-performance cell line development services: Gdansk, Poland Friday, May 9, 2025, 17:00 Hrs [IST] ProBioGen, a Berl ...

a biopharmaceutical contract development and manufacturing organization (CDMO), today announced the expansion of its protein-based and gene therapy service offerings with the addition of Viral ...